Can long term therapy with oral nucleos(t)ide analogs influence the prognosis of chronic hepatitis B-related complications?

被引：2
作者：
Ooi, Marie [1 ,2 ]
Teoh, Narci C. [1 ,2 ]
机构：
[1] Canberra Hosp, Gastroenterol & Hepatol Unit, Garran, ACT 2604, Australia
[2] Canberra Hosp, Australian Natl Univ Med Sch, Garran, ACT 2604, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2012年 / 27卷 / 10期
关键词：
HEPATOCELLULAR-CARCINOMA; LAMIVUDINE; VACCINATION; MANAGEMENT; TRIAL;
D O I：
10.1111/j.1440-1746.2012.07221.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1541 / 1543
页数：3
相关论文
共 50 条
[21]   Hepatitis B core-related antigen: a strong indicator for cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B [J].
Matsumoto, Akihiro .
JOURNAL OF GASTROENTEROLOGY, 2017, 52 (01) :127-128
[22]   The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy [J].
Coffin, C. S. ;
Rezaeeaval, M. ;
Pang, J. X. ;
Alcantara, L. ;
Klein, P. ;
Burak, K. W. ;
Myers, R. P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (11-12) :1262-1269
[23]   Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy [J].
Franze, Maria Stella ;
Saitta, Carlo ;
Lombardo, Daniele ;
Musolino, Cristina ;
Caccamo, Gaia ;
Filomia, Roberto ;
Pitrone, Concetta ;
Cacciola, Irene ;
Pollicino, Teresa ;
Raimondo, Giovanni .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2025, 49 (04)
[24]   Do we need more nucleos(t)ide analogs for the treatment of chronic hepatitis B? [J].
Petersen, Jorg .
JOURNAL OF HEPATOLOGY, 2015, 62 (03) :505-507
[25]   Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs [J].
Siakavellas, Spyros ;
Goulis, John ;
Manolakopoulos, Spilios ;
Triantos, Christos ;
Gatselis, Nikolaos ;
Tsentemidou, Eva ;
Kranidioti, Hariklia ;
Zisimopoulos, Konstantinos ;
Tsoulas, Christos ;
Dalekos, George ;
Papatheodoridis, George .
ANNALS OF GASTROENTEROLOGY, 2021, 34 (01) :73-79
[26]   Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapy [J].
Wang, Meng-Lan ;
Deng, Rong ;
Chen, En-Qiang ;
Tao, Chuan-Min ;
Liao, Juan ;
Zhou, Tao-You ;
Wang, Juan ;
Tang, Hong .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) :301-309
[27]   Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos(t)ide analogs [J].
Lu, Fengmin ;
Wang, Jie ;
Chen, Xiangmei ;
Xu, Dongping ;
Xia, Ningshao .
FRONTIERS OF MEDICINE, 2017, 11 (04) :502-508
[28]   Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients [J].
Kim, Hyo Jin ;
Cho, Ju-Yeon ;
Kim, Yu Jin ;
Gwak, Geum-Youn ;
Paik, Yong-Han ;
Choi, Moon Seok ;
Koh, Kwang Cheol ;
Paik, Seung Woon. ;
Yoo, Byung Chul ;
Lee, Joon Hyeok .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (01) :32-41
[29]   Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long-term nucleos(t)ide analogue therapy [J].
Hsu, Wei-Fan ;
Chen, Chuen-Fei ;
Lai, Hsueh-Chou ;
Su, Wen-Pang ;
Lin, Chia-Hsin ;
Chuang, Po-Heng ;
Chen, Sheng-Hung ;
Chen, Ching-Hsiang ;
Wang, Hung-Wei ;
Huang, Guan-Tarn ;
Peng, Cheng-Yuan .
LIVER INTERNATIONAL, 2018, 38 (04) :627-635
[30]   Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus [J].
Broquetas, Teresa ;
Carrion, Jose A. .
HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2022, 14 :87-100
12345